JAK/STAT3 signal transduction has the ability to suppress tumor immunity, and the application of JAK inhibitors in colon cancer can suppress sporadic colon cancer caused by mutations in APC inhibitory genes, and it may also provide treatment opportunities for other oncogenes with resistance (69). Here, APC is linked to malignant colon neoplasm.